Skip to main content
Ami Shah, MD, Rheumatology, Baltimore, MD, Johns Hopkins Hospital

AmiAalokShahMDMHS

Rheumatology Baltimore, MD

Associate Professor of Medicine, Johns Hopkins University School of Medicine; Director, Division of Rheumatology; Co-Director, Johns Hopkins Scleroderma Center

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shah's full profile

Already have an account?

Education & Training

  • Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public HealthMHS, Clinical Investigation, 2007 - 2009
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Rheumatology, 2006 - 2009
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2003 - 2006
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • MD State Medical License
    MD State Medical License 2009 - 2025
  • CA State Medical License
    CA State Medical License 2004 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Anti‐RNPC3 (U11/U12) Antibodies in Systemic Sclerosis Are Associated with Moderate to Severe Gastrointestinal Dysmotility  
    Robyn T Domsic, Ami A Shah, Thomas A Medsger, Zsuzsanna H McMahan, Arthritis Care & Research

Press Mentions

  • Anti-SSSCA1 Positivity Tied to Cancer Risk in SSc Patients
    Anti-SSSCA1 Positivity Tied to Cancer Risk in SSc PatientsFebruary 12th, 2022
  • Autoantibodies Could Help Predict Cancer Risk in Scleroderma
    Autoantibodies Could Help Predict Cancer Risk in SclerodermaAugust 6th, 2023

Professional Memberships

Other Languages

  • Gujarati

Hospital Affiliations